As cancer cells are characterized by redox imbalance and oxidative stress is a major source of excess Zn2+ in cells (the oxidation of sulfhydryl groups in Zn2+-buffer proteins leads to massive Zn2+ release), S100A1 can predominantly act as a Zn2+-saturated conformer in cancer cells [69]. Here, S100A1 is linked to cancer.